BFC Planning’s Precision BioSciences DTIL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$532K Buy
85,000
+18,000
+27% +$136K 0.02% 573
2026
Q2
$527K Buy
67,000
+39,000
+139% +$274K 0.02% 588
2026
Q1
$154K Buy
28,000
+10,500
+60% +$48.4K 0.01% 960
2025
Q4
$72.8K Buy
+17,500
New +$99.3K ﹤0.01% 1212

Other funds holding DTIL

BFC Planning's DTIL Position: Q3 2026 in Review

BFC Planning increased its Precision BioSciences (DTIL) stake by 27% in Q3 2026, buying an estimated $136K and bringing the position to 85,000 shares worth $532K. The position accounts for 0.02% of the portfolio, ranked #573.

BFC Planning first reported a position in DTIL in Q4 2025 and has held it in 4 quarters since. 75 funds tracked by Wall St. Rank hold DTIL as of Q3 2026.

  • BFC Planning held 85,000 shares of Precision BioSciences worth $532K as of Q3 2026.
  • BFC Planning bought 18,000 Precision BioSciences shares in Q3 2026, an estimated $136K.
  • Precision BioSciences made up 0.02% of BFC Planning's portfolio in Q3 2026, its #573 holding.
  • BFC Planning first reported a position in Precision BioSciences in Q4 2025 and has held it in 4 quarters since.
  • 75 funds tracked by Wall St. Rank held Precision BioSciences as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.